ASX - By Stock
|
OSL |
Re:
Ann: 200th patient treated with the OncoSil device
|
|
Garris1234
|
72 |
21K |
0 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
72
|
21K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 200th patient treated with the OncoSil device
|
|
Garris1234
|
72 |
21K |
0 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
72
|
21K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First Austria-based treatments utilising the OncoSil device
|
|
Garris1234
|
40 |
10K |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
40
|
10K
|
4
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Garris1234
|
58 |
14K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Garris1234
|
58 |
14K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Garris1234
|
58 |
14K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
Garris1234
|
58 |
14K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
14K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 84 German hospitals can negotiate fee for Oncosil device
|
|
Garris1234
|
39 |
11K |
1 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
39
|
11K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First two commercial patient treatments in Greece
|
|
Garris1234
|
4 |
2.0K |
2 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
4
|
2.0K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Insurance Adoption
|
|
Garris1234
|
67 |
23K |
1 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
67
|
23K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil advancements in Pancreatic Cancer Treatment
|
|
Garris1234
|
13 |
2.9K |
0 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
13
|
2.9K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4E and Annual Report
|
|
Garris1234
|
31 |
12K |
1 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
31
|
12K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4E and Annual Report
|
|
Garris1234
|
31 |
12K |
0 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
31
|
12K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Scientia Doses Ahead of Schedule in Phase I/II UTI Trial
|
|
Garris1234
|
25 |
7.4K |
3 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
25
|
7.4K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Scientia Doses Ahead of Schedule in Phase I/II UTI Trial
|
|
Garris1234
|
25 |
7.4K |
2 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
25
|
7.4K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Scientia Doses Ahead of Schedule in Phase I/II UTI Trial
|
|
Garris1234
|
25 |
7.4K |
2 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
25
|
7.4K
|
2
|
|
ASX - By Stock
|
RCE |
Re:
Ann: First Cohort Dosed in Rapid Infusion Phase I/II UTI study
|
|
Garris1234
|
22 |
7.7K |
9 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
22
|
7.7K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Change of Director's Interest Notice - J Graham
|
|
Garris1234
|
27 |
7.6K |
2 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
27
|
7.6K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer Results and Shortfall Notification
|
|
Garris1234
|
133 |
41K |
0 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
133
|
41K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Entitlement Offer Results and Shortfall Notification
|
|
Garris1234
|
133 |
41K |
0 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
133
|
41K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First patient enrolled in the TRIPP-FFX Clinical Study
|
|
Garris1234
|
11 |
4.2K |
0 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
11
|
4.2K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: First patient enrolled in the TRIPP-FFX Clinical Study
|
|
Garris1234
|
11 |
4.2K |
0 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
11
|
4.2K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Half Yearly Report and Accounts
|
|
Garris1234
|
14 |
4.8K |
1 |
04/03/23 |
04/03/23 |
ASX - By Stock
|
14
|
4.8K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two key treatment centres treat first patients with OncoSil
|
|
Garris1234
|
23 |
10K |
0 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
23
|
10K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Garris1234
|
95 |
39K |
1 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
95
|
39K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Garris1234
|
95 |
39K |
0 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
95
|
39K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Investor Update
|
|
Garris1234
|
95 |
39K |
2 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
95
|
39K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Ann: CE Mark Update
|
|
Garris1234
|
395 |
273K |
6 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
395
|
273K
|
6
|
|